$80-$100M with SM6 Phase II on completion but that's still being relatively conservative imo with FDA granting Orphan designation yesterday and doesn't take into account any move out of left field made on the company should it occur.
I've stated my reasoning previously. I'm not going to repeat it.
For an extra source though that comes to about the same figures Stuart Roberts BP report released October 2012 had a $0.12 (base case) - $0.21 12 month target. Worth noting that basically all objectives in that report have also now been achieved.
Stuart Roberts / Bell Potter - A Diamond In The Rough - Nov. 2012
.
- Forums
- ASX - By Stock
- PAB
- valuation time
valuation time, page-3
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
-0.001(7.14%) |
Mkt cap ! $13.37M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $505 | 80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 5901591 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1528945 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 5901591 | 0.006 |
17 | 7830976 | 0.005 |
7 | 4425000 | 0.004 |
6 | 2930016 | 0.003 |
2 | 4520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1528945 | 4 |
0.008 | 2057547 | 3 |
0.009 | 133332 | 1 |
0.010 | 1592000 | 4 |
0.011 | 1080000 | 2 |
Last trade - 15.44pm 16/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |